Bunge Global SA - Q3 2024 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended September 30, 2024. Bunge Global SA is a global agribusiness company organized into four reportable segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The company is currently in the process of acquiring Viterra Limited, a transaction expected to close in the coming months.
Key Financial Metrics
| Metric | Q3 2024 | Q3 2023 | YTD 9M 2024 | YTD 9M 2023 |
|---|---|---|---|---|
| Net Sales | $12,908 million | $14,227 million | $39,566 million | $44,604 million |
| Gross Profit | $772 million | $1,045 million | $2,312 million | $3,591 million |
| Net Income (Attributable to Bunge) | $221 million | $373 million | $535 million | $1,627 million |
| Diluted EPS | $1.56 | $2.47 | $3.73 | $10.71 |
| Total Segment EBIT | $407 million | $584 million | $1,025 million | $2,382 million |
| Cash from Operations (9M) | $847 million (vs. $1,860 million prior year) | |||
| Total Debt | $6,195 million (as of Sept 30, 2024) | |||
| Cash & Equivalents | $2,836 million (as of Sept 30, 2024) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 9% in Q3 and 11% YTD compared to the prior year, driven primarily by lower average sales prices in the Agribusiness and Refined and Specialty Oils segments due to stabilized global supply and demand.
- Profitability Compression: Net income attributable to Bunge shareholders dropped 41% in Q3 and 67% YTD. Total Segment EBIT declined 30% in Q3 and 57% YTD.
- Segment Performance:
- Agribusiness: EBIT fell 30% in Q3 and 62% YTD, impacted by lower gross profit in North American oilseed processing and a $19 million impairment charge on a minority investment.
- Sugar and Bioenergy: EBIT plummeted 89% in Q3 and 93% YTD due to unfavorable results from the BP Bunge Bioenergia joint venture, including foreign exchange losses and lower ethanol prices.
- Milling: EBIT increased 91% YTD despite a 20% sales drop, driven by higher gross profit in South American wheat milling.
- Debt Increase: Total debt rose to $6.195 billion, an increase of $1.3 billion from year-end 2023, primarily due to the issuance of $2.0 billion in Senior Notes to fund the pending Viterra acquisition.
Guidance, Outlook, and Risks
- Viterra Acquisition: Bunge is actively pursuing the acquisition of Viterra Limited. The company has secured $8.0 billion in acquisition financing (reduced to $6.0 billion following the Senior Notes issuance) and issued $2.0 billion in new Senior Notes. The deal is subject to regulatory approvals and is expected to close in the next several months.
- Capital Allocation: The company continues its share repurchase program, with $800 million remaining available. Dividends of $0.68 per share were paid in Q3, with an annualized rate of $2.72 approved by shareholders.
- Divestitures: Bunge closed the sale of its 50% interest in BP Bunge Bioenergia in October 2024 for approximately $828 million. It also entered an agreement to divest 40% of Bunge Iberica SA to Repsol, expected to close in early 2025.
- Risks: Key risks include the successful completion and integration of the Viterra acquisition, volatility in agricultural commodity prices, foreign exchange fluctuations (particularly in South America), and ongoing legal proceedings in Brazil regarding labor and tax claims.
Investor Verification Checklist
- Viterra Closing Timeline: Verify the status of remaining regulatory approvals and the expected closing date for the Viterra acquisition.
- BP Bunge Bioenergia Sale: Confirm the final net consideration received from the October 2024 sale of the joint venture and any subsequent adjustments.
- Debt Covenants: Review compliance with financial covenants (minimum current ratio, maximum debt-to-capitalization) given the increased debt load from the Viterra financing.
- Impairment Charges: Assess the nature and frequency of impairment charges, specifically the $19 million charge in the Agribusiness segment and potential future impacts from the Sugar and Bioenergy segment.
- Working Capital Trends: Monitor the decline in working capital ($8.228 billion) and the increase in the current portion of long-term debt ($663 million) to ensure liquidity remains sufficient for operations and the pending acquisition.